Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nutropin AQ in Children With Optic Nerve Hypoplasia
NCT00140413Phase 4Completed
- Sponsor
- Children's Hospital Los Angeles
- Start
- Dec 2004
- Primary completion
- Feb 2014
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of somatropin in growth hormone deficiency (GHD), sponsored by Children's Hospital Los Angeles. Primary endpoint: Change in Anthropometric Measures Over Time at 36 months. Started Dec 2004; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00140413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140413.